Are higher doses of rifaximin more effective for the treatment of small-intestinal bacterial overgrowth?
Beglinger
Christoph
C
Department of Gastroenterology, University Hospital, Basel, Switzerland. beglinger@tmr.ch
Degen
Lukas
L